Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.

The objective of this placebo controlled double-blind multicentre (six centres) trial was to investigate the safety and efficacy of ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor antagonist with modest intrinsic sympathomimetic activity (ISA), in hypertensive patients. Fifty-nine patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dahlöf, B, Danielson, M, Andersson, O, Thulin, T, Ohman, P, Mörlin, C, Boberg, J, Karlberg, B E, Jern, S, Hansson, L
Format: Artigo
Jezik:Inglês
Izdano: 1984
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1463665/
https://ncbi.nlm.nih.gov/pubmed/6152175
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki